⌘K
Loading ticker…
Prelude Therapeutics Incorporated · Healthcare · Pharmaceutical Products
As of 2026-06-26, Prelude Therapeutics Incorporated (PRLD) has a 3-month relative strength percentile of 84 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 92. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.4%, relative volume 10.52×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 84, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
PRLD is in a stage 2 uptrend, week 1. Currently in a 50-day base; basing ADR 10.3% (broad 11.4%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 0.6% / 60.7%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
PRLD is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $3M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $3M |
| VXFVanguard Extended Market ETF | 0.00% | $900K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PRLD Jan avg: -16.87% median: -18.45% win: 25% σ: 17.61% n: 4 2022-04-12 → 2026-05-29 | PRLD Feb avg: 9.50% median: 9.91% win: 50% σ: 37.03% n: 4 2022-04-12 → 2026-05-29 | PRLD Mar avg: 9.01% median: 5.71% win: 100% σ: 10.86% n: 4 2022-04-12 → 2026-05-29 | PRLD Apr avg: 8.86% median: 13.33% win: 60% σ: 32.89% n: 5 2022-04-12 → 2026-05-29 | PRLD May avg: -10.55% median: -8.50% win: 20% σ: 9.91% n: 5 2022-04-12 → 2026-05-29 | PRLD Jun avg: -1.19% median: -4.84% win: 25% σ: 18.57% n: 4 2022-04-12 → 2026-05-29 (current) | PRLD Jul avg: 11.55% median: -3.93% win: 25% σ: 37.34% n: 4 2022-04-12 → 2026-05-29 | PRLD Aug avg: 19.04% median: 19.70% win: 50% σ: 35.99% n: 4 2022-04-12 → 2026-05-29 | PRLD Sep avg: -16.63% median: -12.68% win: 25% σ: 32.86% n: 4 2022-04-12 → 2026-05-29 | PRLD Oct avg: -18.93% median: -20.41% win: 50% σ: 28.85% n: 4 2022-04-12 → 2026-05-29 | PRLD Nov avg: 22.18% median: 2.68% win: 50% σ: 49.70% n: 4 2022-04-12 → 2026-05-29 | PRLD Dec avg: 28.40% median: 25.22% win: 75% σ: 33.85% n: 4 2022-04-12 → 2026-05-29 |